Jay Kailash Namkeen shareholders approve ₹15.25 cr preferential issue
- Shareholders approved all 12 AGM resolutions with 100% support from participating voters
- Promoters and public non-institutions accounted for all votes polled, with institutions abstaining
- A ₹15.25 cr preferential equity issue for non-cash consideration was authorized
- Seven new directors, including four independents, were appointed to the board

*this image is generated using AI for illustrative purposes only.
Jay Kailash Namkeen shareholders unanimously approved all resolutions at its fifth annual general meeting, confirming a ₹15.25 crore capital infusion and significant board restructuring.
The company disclosed the final voting results on September 16, 2026, for the AGM held on September 12, 2026, at RPJ Hotel in Rajkot. Shareholders representing 18,13,018 equity shares, or 36.28% of the total outstanding shares as on the cut-off date of September 5, 2026, cast their votes. All 12 ordinary and special resolutions passed with 100% support among those who voted, with no votes recorded against any agenda item.
Voting Participation
Participation was driven primarily by promoter and non-institutional public shareholders. Institutional investors did not participate in the voting process.
| Category | Shares Held | Votes Polled | Participation % |
|---|---|---|---|
| Promoter and Promoter Group | 10,15,246 | 10,07,231 | 99.21% |
| Public – Institutions | 40,000 | 0 | 0% |
| Public – Non-Institutions | 39,41,687 | 8,05,787 | 20.44% |
| Total | 49,96,933 | 18,13,018 | 36.28% |
Promoters voted via polling paper at the venue, while public non-institutional shareholders utilized both remote e-voting and polling facilities. The scrutinizer for the process was Ms. Shikha Rai of Mamta Binani and Associates.
Board Appointments Confirmed
Shareholders approved the appointment of seven new directors to expand the board’s oversight capabilities. Three individuals were appointed as directors, while four were appointed as independent directors through special resolutions.
- Chirag Jayeshbhai Archlani (Director)
- Aadi N Kalavadia (Director)
- Sanjay Chandrakant Rao (Non-Executive Director)
- Pooja Jamnabhai Varsani (Independent Director)
- Dipakbhai Bhikhubhai Hariyani (Independent Director)
- Vipin Vishvanath Agrawal (Independent Director)
- Satnam Singh Chandok (Independent Director)
Managing Director Neel Narendrabhai Pujara was also re-appointed by rotation. The meeting further approved the sitting fees payable to the newly appointed independent directors.
Preferential Equity Issue
The most significant financial outcome was the approval of a special resolution for a preferential allotment of equity shares. The company is authorized to issue up to 33,74,375 equity shares of face value ₹10 each at an issue price of ₹45.19 per share.
| Parameter | Details |
|---|---|
| Number of Shares | 33,74,375 |
| Face Value | ₹10 |
| Issue Price | ₹45.19 |
| Premium | ₹35.19 per share |
| Total Proceeds | ₹15,24,88,006 |
The shares are being issued for consideration other than cash, representing a capital infusion of approximately ₹15.25 crore into the company.
Other Business
M/s. MRB & Associates, Chartered Accountants, were appointed as Statutory Auditors for a term of five consecutive years. The audited standalone financial statements for the fiscal year ended March 31, 2026, were considered and adopted during the proceedings.
Historical Stock Returns for Jay Kailash Namkeen
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.00% | -3.96% | -18.74% | +197.10% | +11.26% | -37.86% |
How will the ₹15.25 crore capital infusion via non-cash consideration impact Jay Kailash Namkeen's balance sheet liquidity and debt-to-equity ratio in the coming fiscal year?
What specific strategic initiatives or expansion plans is the company expected to fund with the proceeds from this preferential allotment?
Given that institutional investors did not participate in the AGM, will the new board composition and capital structure improve investor confidence and attract institutional interest in future quarters?


































